Related Experiment Video
Updated: Feb 11, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Improving testing and description of treatment effect in clinical trials with survival outcomes
1Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA.
Abstract:
Cox model inference and the log-rank test have been the cornerstones for design and analysis of clinical trials with survival outcomes. In this article, we summarize some recently developed methods for analyzing survival data when the hazards may possibly be nonproportional and also propose some new estimators for summary measures of the treatment effect. These methods utilize the short-term and long-term hazard ratio model proposed in Yang and Prentice (2005), which contains the Cox model and also accommodates various nonproportional hazards scenarios. Without the proportional hazards assumption, these methods often improve the log-rank test and inference procedures based on the Cox model, as well as nonparametric procedures currently available in the literature. The proposed methods have sound theoretical justifications and can be computed quickly. R codes for implementing them are available. Detailed illustrations with 3 clinical trials are provided.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests